• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.

作者信息

Shenoy Surendra, Allon Michael, Beathard Gerald, Brouwer-Maier Deborah, Dember Laura M, Glickman Mark, Lee Celeste, Litchfield Terry, Lok Charmaine, Huber Thomas, Roy-Chaudhury Prabir, Work Jack, West Melissa, Wasse Haimanot

机构信息

Due to the number of contributing authors, the affiliations are provided in the Supplemental Material .

出版信息

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27.

DOI:10.2215/CJN.13321216
PMID:29487092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5967685/
Abstract
摘要

相似文献

1
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.血液透析血管通路的临床试验终点：背景、原理及定义
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27.
2
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.FDA 对血液透析血管通路研究的监管观点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24.
3
Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.介入性动静脉透析通路研究的定义和终点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):501-512. doi: 10.2215/CJN.11531116. Epub 2017 Jul 20.
4
Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.老年血液透析患者的血管通路类型与临床结局。
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1823-1830. doi: 10.2215/CJN.01410217. Epub 2017 Aug 10.
5
Hemodialysis access in the pediatric patient population.儿科患者群体中的血液透析通路
Am J Surg. 1994 Aug;168(2):197-201. doi: 10.1016/s0002-9610(94)80067-7.
6
Vascular Access: Inukshuk.血管通路：因纽特石堆路标。
Adv Chronic Kidney Dis. 2015 Nov;22(6):413-7. doi: 10.1053/j.ackd.2015.09.002.
7
Stent-graft arteriovenous fistula: an endovascular technique in hemodialysis access.覆膜支架动静脉内瘘：一种用于血液透析通路的血管内技术。
J Endovasc Surg. 1998 Feb;5(1):18-23. doi: 10.1583/1074-6218(1998)005<0018:SGAFAE>2.0.CO;2.
8
Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.合成血管血液透析通路与天然动静脉瘘：成本效用分析。
Ann Surg. 2012 Jan;255(1):181-6. doi: 10.1097/SLA.0b013e31822f4e9b.
9
Current strategies for vascular access in patients on hemodialysis.血液透析患者目前的血管通路策略。
ASAIO J. 1992 Oct-Dec;38(4):743-4.
10
Vascular access in hemodialysis: issues, management, and emerging concepts.血液透析中的血管通路：问题、管理及新观念
Cardiol Clin. 2005 Aug;23(3):249-73. doi: 10.1016/j.ccl.2005.04.004.

引用本文的文献

1
Predicting long-term patency of radiocephalic arteriovenous fistulas with machine learning and the PREDICT-AVF web app.利用机器学习和PREDICT-AVF网络应用程序预测桡动脉-头静脉内瘘的长期通畅情况。
Sci Rep. 2025 Jun 1;15(1):19203. doi: 10.1038/s41598-025-04310-y.
2
Long-term outcomes of refractory central venous occlusive disease treated by stent deployment in patients undergoing maintenance hemodialysis.接受维持性血液透析的患者中，经支架置入治疗难治性中心静脉闭塞性疾病的长期预后。
Ren Fail. 2025 Dec;47(1):2463579. doi: 10.1080/0886022X.2025.2463579. Epub 2025 Feb 16.
3
Outcomes of Endovascular Treatment for Salvaging Failed Hemodialysis Arteriovenous Fistula - Role of Balloon Angioplasty as Initial Therapy.挽救失败的血液透析动静脉内瘘的血管内治疗结果——球囊血管成形术作为初始治疗的作用
Indian J Nephrol. 2024 Nov-Dec;34(6):583-588. doi: 10.25259/ijn_539_23. Epub 2024 Jun 24.
4
Outcomes Following Arteriovenous Fistula Creation in Medicare Beneficiaries With End-Stage Kidney Disease.终末期肾病医疗保险受益人的动静脉内瘘造瘘术后结局
Am J Cardiol. 2025 Jan 1;234:79-86. doi: 10.1016/j.amjcard.2024.10.006. Epub 2024 Oct 22.
5
Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial.通过模拟目标试验评估全身肝素在动静脉内瘘创建过程中的有效性。
Am J Epidemiol. 2025 Mar 4;194(3):651-658. doi: 10.1093/aje/kwae098.
6
Evaluating national guideline concordance of recurrent interventions after radiocephalic arteriovenous fistula creation.评估头静脉桡动脉内瘘术后再干预的国家指南一致性。
J Vasc Surg. 2023 Apr;77(4):1206-1215.e2. doi: 10.1016/j.jvs.2022.12.017. Epub 2022 Dec 22.
7
Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone.与单纯普通血管成形术相比，使用含白藜芦醇辅料和紫杉醇涂层球囊对功能失调的透析内瘘或移植物进行血管成形术可提高初次通畅率。
J Clin Med. 2022 Dec 14;11(24):7405. doi: 10.3390/jcm11247405.
8
The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study.臂丛神经阻滞诱导的血管扩张对终末期肾病患者动静脉通路术后血栓形成发展的影响：一项回顾性研究。
Int J Environ Res Public Health. 2022 Nov 17;19(22):15158. doi: 10.3390/ijerph192215158.
9
Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice.血管通路功能测量的研究方案：在血液透析中的验证研究（VALID）：一项多中心、多国的验证研究，旨在评估在临床实践中测量血管通路功能的准确性和可行性。
BMC Nephrol. 2022 Nov 19;23(1):372. doi: 10.1186/s12882-022-02987-1.
10
Radiocephalic Arteriovenous Fistula Patency and Use: A Post Hoc Analysis of Multicenter Randomized Clinical Trials.桡动脉-头静脉内瘘的通畅性及使用情况：多中心随机临床试验的事后分析
Ann Surg Open. 2022 Aug 23;3(3):e199. doi: 10.1097/AS9.0000000000000199. eCollection 2022 Sep.

本文引用的文献

1
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.FDA 对血液透析血管通路研究的监管观点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24.
2
Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.介入性动静脉透析通路研究的定义和终点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):501-512. doi: 10.2215/CJN.11531116. Epub 2017 Jul 20.
3
Recommended Clinical Trial End Points for Dialysis Catheters.推荐的透析导管临床试验终点。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):495-500. doi: 10.2215/CJN.12011116. Epub 2017 Jul 20.
4
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.克服肾脏健康领域的障碍——打造创新平台。
J Am Soc Nephrol. 2016 Jul;27(7):1902-10. doi: 10.1681/ASN.2015090976. Epub 2016 Apr 28.
5
Fostering innovation, advancing patient safety: the kidney health initiative.促进创新，推进患者安全：肾脏健康倡议。
Clin J Am Soc Nephrol. 2013 Sep;8(9):1609-17. doi: 10.2215/CJN.01140113. Epub 2013 Jun 6.
6
Standardized definitions for hemodialysis vascular access.血液透析血管通路的标准化定义。
Semin Dial. 2011 Sep-Oct;24(5):515-24. doi: 10.1111/j.1525-139X.2011.00969.x. Epub 2011 Sep 9.
7
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.血管外科学会：动静脉血液透析通路手术建立与维护的临床实践指南
J Vasc Surg. 2008 Nov;48(5 Suppl):2S-25S. doi: 10.1016/j.jvs.2008.08.042.
8
Reporting standards for percutaneous interventions in dialysis access.透析通路经皮介入治疗的报告标准。
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S433-42. doi: 10.1097/01.rvi.0000094618.61428.58.
9
III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.三、NKF-K/DOQI血管通路临床实践指南：2000年更新版
Am J Kidney Dis. 2001 Jan;37(1 Suppl 1):S137-81. doi: 10.1016/s0272-6386(01)70007-8.